Related references
Note: Only part of the references are listed.Identification of O-glycosylated Proteins That Are Aberrantly Excreted in the Urine of Patients with Early Stage Ovarian Cancer
Alan Kang-Wai Mu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Detection of Differential Levels of Proteins in the Urine of Patients with Endometrial Cancer: Analysis Using Two-Dimensional Gel Electrophoresis and O-Glycan Binding Lectin
Alan Kang-Wai Mu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
Toon Van Gorp et al.
PROTEOME SCIENCE (2012)
A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
Wouter Wegdam et al.
PROTEOME SCIENCE (2012)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma
Makiko Hoshino et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology
Yi-Ting Chen et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Serum Biomarkers for Early Detection of Gynecologic Cancers
Yutaka Ueda et al.
Cancers (2010)
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
Digant Gupta et al.
JOURNAL OF OVARIAN RESEARCH (2009)
Proteiomic patterns for endometrial cancer using SELDI-TOF-MS
Li-rong Zhu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2008)
Biomarker discovery for ovarian cancer using SELDI-TOF-MS
Hui Zhang et al.
GYNECOLOGIC ONCOLOGY (2006)
Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapyof tumours
A Kobata et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Share Paper
